NCT02912559 2026-02-02Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairNational Cancer Institute (NCI)Phase 3 Active not recruiting712 enrolled